Rongrong Wu

Roswell Park Comprehensive Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

David N. Brindley

University of Alberta

CANADA

View details

Yoshihisa Tokumaru

Assistant professor

Gifu University Graduate School of Medicine

JAPAN

View details

Yoshiya Horimoto

Juntendo University Graduate School of Medicine

JAPAN

View details

Kazuaki Takabe

Alfiero Foundation Chair and Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rongrong Wu

Research Interests

Explore related searches

Contact this professor

Articles (12)

Emerging measurements for tumor-infiltrating lymphocytes in breast cancer

Intestinal ultrasound for intestinal Behçet disease reflects endoscopic activity and histopathological findings

Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression

Decreased Lipid Phosphate Phosphatase 1/3 and Increased Lipid Phosphate Phosphatase 2 Expression in the Human Breast Cancer Tumor Microenvironment Promotes Tumor Progression and Immune System Evasion

Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer

The Role of the Microbiome on the Pathogenesis and Treatment of Colorectal Cancer

Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness

Development of a novel BRCAness score that predicts response to PARP inhibitors.

Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer

NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation

Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer.

Clinical Relevance of Estrogen Reactivity in the Breast Cancer Microenvironment.

Collaborators (4)

David N. Brindley

Yoshihisa Tokumaru

Yoshiya Horimoto

Kazuaki Takabe

Make your next move.